Skip to content
Toggle main navigation
MC Lounge logo
MC Lounge logo
  • Events
  • News
  • Visit Myeloma Canada
MoreOpen dropdown to see remaining menu items
    Log in
    Join Us I Demande d'adhésion
    Select an available language
    EN
    Contact
    Myeloma Canada
    1255 TransCanada, Suite 160, Dorval, QC H9P 2V4

    Canada

    [email protected]
    1-888-798‑5771
    Links
    About us
    Our groups
    Our updates
    Newsletter sign up
    Privacy policy
    Community engagement platform by Hivebrite.

    News

    Highlighted News

    Results (2)

    Newest
    Myeloma Canada’s 2025 Aldo Del Col Research Grant: Four Projects Advancing Myeloma Treatment

    Myeloma Canada’s 2025 Aldo Del Col Research Grant: Four Projects Advancing Myeloma Treatment

    Myeloma Canada’s 2025 Aldo Del Col Research Grant: Four Projects What does the future of myeloma research look like? Find out how Canadian researchers are shaping it. Supported by the 2025 Aldo Del Col Research Grant, named in honour of Myeloma Canada's co-founder, four Canadian researchers are working toward a future where life is uninterrupted by myeloma. Learn more:https://myeloma.ca/2026/04/16
    May 5, 2026
    📢PRESS RELEASE: National reimbursement negotiations for Carvykti® terminated without agreement, devastating Canadians with myeloma

    📢PRESS RELEASE: National reimbursement negotiations for Carvykti® terminated without agreement, devastating Canadians with myeloma

    Dear community,The following is a press release issued by Myeloma Canada in the wake of learning that the pan-Canadian Pharmaceutical Alliance (pCPA) has terminated reimbursement negotiations – without agreement – for Carvykti®, an extremely promising new CAR T-cell therapy for myeloma patients. This issue will be an ongoing campaign and is not likely to be resolved in the short term as reimbursem
    September 30, 2025